Suppr超能文献

与急性肾损伤相关的医疗保健费用。

Health Care Costs Associated with AKI.

机构信息

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

出版信息

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1733-1743. doi: 10.2215/CJN.00950117. Epub 2017 Oct 19.

Abstract

BACKGROUND AND OBJECTIVES

An understanding of the health care resource use associated with AKI is needed to frame the investment and cost-effectiveness of strategies to prevent AKI and promote kidney recovery.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We assembled population-based cohort of adults hospitalized in Alberta between November of 2002 and March of 2009 without ESRD or an eGFR<15 ml/min per 1.73 m. Outpatient serum creatinine measurements 6 months preceding admission defined baseline kidney function, and serum creatinine during the first 14 days of hospitalization defined Acute Kidney Injury Network stage; kidney recovery defined as serum creatinine within 25% of baseline and independence from dialysis was assessed at 90 days after AKI. Health care utilization and costs (in 2015 Canadian dollars) were determined from inpatient, outpatient, and physician claims datasets during the index hospitalization, recovery period (90 days post-AKI assessment), and 3-12 months post-AKI. A fully adjusted generalized linear model regression analysis was used to estimate costs associated with AKI.

RESULTS

Of 239,906 hospitalized subjects, 25,495 (10.6%), 4598 (1.9%), 2493 (1.0%), and 670 (0.3%) had Acute Kidney Injury Network stages 1, 2, 3 without dialysis, and 3 with dialysis, respectively. Greater severity of AKI was associated with incremental increases in length of stay (+2.8; 95% confidence interval, 1.4 to 4.3 to +7.4; 95% confidence interval, 7.2 to 7.5 days) and costs (+$3779; 95% confidence interval, $3555 to $4004 to +$18,291; 95% confidence interval, $15,573 to $21,009 Canadian dollars) from admission to recovery assessment (3 months). At months 3-12 postadmission, compared with subjects without AKI, AKI with kidney recovery and AKI without kidney recovery were associated with incremental costs of +$2912-$3231 and +$6035-$8563 Canadian dollars, respectively. The estimated incremental cost of AKI in Canada is estimated to be over $200 million Canadian dollars per year.

CONCLUSIONS

Severity of AKI, need for dialysis, and lack of kidney recovery are associated with significant health care costs in hospitalized patients and persist a year after admission. Strategies to identify, prevent, and facilitate kidney recovery are needed.

摘要

背景和目的

为了制定预防急性肾损伤(AKI)和促进肾脏恢复的策略的投资和成本效益,需要了解与 AKI 相关的医疗资源使用情况。

设计、地点、参与者和测量方法:我们收集了 2002 年 11 月至 2009 年 3 月期间在艾伯塔省住院的成年人的基于人群的队列,这些成年人没有终末期肾病或估计肾小球滤过率(eGFR)<15ml/min/1.73m。入院前 6 个月的门诊血清肌酐测量值定义了基线肾功能,入院后第 14 天的血清肌酐定义了急性肾损伤网络(AKIN)分期;在 AKI 发生后 90 天,通过血清肌酐恢复到基线的 25%以内和无需透析来评估肾脏恢复。在索引住院期间、恢复期(AKI 评估后 90 天)和 AKI 后 3-12 个月,从住院、门诊和医生索赔数据集中确定了医疗保健利用和费用(以 2015 年加元计算)。使用完全调整的广义线性模型回归分析来估计与 AKI 相关的成本。

结果

在 239906 名住院患者中,分别有 25495 名(10.6%)、4598 名(1.9%)、2493 名(1.0%)和 670 名(0.3%)患有 AKIN 分期 1、2、3 而无需透析,以及 3 期伴透析。AKI 的严重程度与住院时间的增加有关(+2.8;95%置信区间,1.4 至 4.3 至+7.4;95%置信区间,7.2 至 7.5 天)和成本(+3779 加元;95%置信区间,3555 至 4004 至+18291 加元;95%置信区间,15573 至 21009 加元),从入院到恢复期(3 个月)评估。在入院后 3-12 个月时,与无 AKI 的患者相比,AKI 有肾脏恢复和 AKI 无肾脏恢复分别与增量成本 +2912-3231 加元和+6035-8563 加元相关。估计加拿大 AKI 的估计增量成本每年超过 2 亿加元。

结论

AKI 的严重程度、需要透析和肾脏恢复不良与住院患者的大量医疗保健费用相关,并在入院后持续一年。需要采取策略来识别、预防和促进肾脏恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94bd/5672961/5115f4b1e815/CJN.00950117absf1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验